ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 914

Occupational Exposure to Combustion Products and Risk of Developing Rheumatoid Arthritis

Anna Ilar1, Pernilla Wiebert1,2, Saedis Saevarsdottir3, Johan Askling4,5, Per Gustavsson1,2 and Lars Alfredsson1,2, 1The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Stockholm County Council, Centre for Occupational and Environmental Medicine, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 4Rheumatology unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, 5Unit of Clinical Epidemiology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Environmental factors, environmental pathogens, Rheumatoid arthritis (RA) and work, Workforce

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Epidemiology and Public Health II: Non-Genetic Risk Factors for Incident Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Studies have suggested a potential association between traffic pollutants and rheumatoid arthritis (RA), but findings have been inconclusive. We therefore assessed the risk of RA from occupational exposure to combustion products in a large population-based case-control study.

Methods:

We included participants living in Sweden from 2006 to 2013. Incident cases of RA were enrolled from the Swedish Rheumatology Quality Register. Ten controls per case, matched on sex, age and county, were enrolled from the total population register. Work histories were available through population and housing censuses. We estimated exposure to asphalt fumes, diesel engine exhaust and polycyclic aromatic hydrocarbons from 1955 to 1995 with job-exposure matrices. Conditional logistic regression was used to estimate the risks of two histological subtypes of RA (seropositive or seronegative RA) from exposure to either of the combustion products taken separately or all of them combined. All main exposures were adjusted for potential confounding from each other as well as from respirable crystalline silica dust and household disposable income. The results are presented for men and women separately.

Results:

We analyzed 9 180 cases and 81 367 controls. Ever exposure to diesel engine exhaust in men was associated with a marginally higher risk of seropositive RA (OR: 1.11, 95 % CI: 1.00-1.23), which was slightly higher among workers with at least 20 years of exposure (OR: 1.22, 95 % CI: 1.00-1.49). More than 20 years of asphalt fumes exposure was also associated with a higher risk estimate for seropositive RA among men (OR: 1.87, 95 % CI: 1.05-3.31). Being exposed to asphalt fumes, diesel engine exhaust or polycyclic aromatic hydrocarbons combined for more than 20 years resulted in an OR of 1.22 (95 % CI: 1.03-1.45) among men for seropositive RA and 0.98 (95 % CI: 0.77-1.23) for seronegative RA.

Women were less likely than men to have been exposed to combustion products during work and few female workers had been exposed for a longer period of time. Ever exposure to polycyclic aromatic hydrocarbons in women was associated with a potentially higher risk of seropositive RA (OR: 1.22, 95 % CI: 1.00-1.48). Women exposed to asphalt fumes, diesel engine exhaust or polycyclic aromatic hydrocarbons combined for more than 20 years had an OR of 0.91 (95 % CI: 0.36-2.29) for RA overall.

Conclusion:

Long-term exposure to combustion products may increase the risk of seropositive RA among men after adjustments for potential confounders.


Disclosure: A. Ilar, None; P. Wiebert, None; S. Saevarsdottir, None; J. Askling, AbbVie, Eli Lilly, Janssen, Merck, Pfizer, Roche, UCB, Samsung, 2; P. Gustavsson, None; L. Alfredsson, None.

To cite this abstract in AMA style:

Ilar A, Wiebert P, Saevarsdottir S, Askling J, Gustavsson P, Alfredsson L. Occupational Exposure to Combustion Products and Risk of Developing Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/occupational-exposure-to-combustion-products-and-risk-of-developing-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/occupational-exposure-to-combustion-products-and-risk-of-developing-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology